FTC Warns Pharma of Patent Manipulation; AbbVie’s Humira Patent Expires
Last week the Federal Trade Commission issued a warning to pharmaceutical companies about exploiting loopholes in the patent process. In particular, patents…
Waxing Lyrica: Big Pharma Subverts the Patent Process
This December, the patent for Pfizer’s goldmine drug Lyrica will expire. Lyrica is prescribed for neuropathic illnesses such as epilepsy and fibromyalgia….